Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel

por Sams, L., Kruger, S., Heinemann, V., Bararia, D., Haebe, S., Alig, S., Haas, M., Zhang, D., Westphalen, C. B., Ormanns, S., Metzger, P., Werner, J., Weigert, O., von Bergwelt-Baildon, M., Rataj, F., Kobold, S., Boeck, S.
Publicado 2021